Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10087259 Depleting tumor-specific tregs

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
April 28, 2015
0
Date of Patent
October 2, 2018
0
Patent Application Number
14698600
0
Patent Citations Received
‌
US Patent 12065497 Methods of treatment using CCR8 antibodies
0
‌
US Patent 11639393 Anti-CCR8 antibodies
0
‌
US Patent 11692038 Antibodies that bind chemokine (C-C motif) receptor 8 (CCR8)
0
‌
US Patent 11427640 CCR8 antibodies for therapeutic applications
‌
US Patent 11873342 Anti-CCR8 monoclonal antibodies and uses thereof
0
‌
US Patent 11932696 Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells
0
‌
US Patent 10550191 Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8
0
Patent Inventor Names
Alexander Rudensky
0
George Plitas
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10087259
0
Patent Primary Examiner
‌
Daniel C Gamett
0

Find more entities like US Patent 10087259 Depleting tumor-specific tregs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo